Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells.

Source:http://linkedlifedata.com/resource/pubmed/id/15321987

Download in:

View as

General Info

PMID
15321987